Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Lymphoid 2Head & Neck 2Genitourinary 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1Classical hematology 1

Conditions

Head and Neck Neoplasms 2Lung Neoplasms 1

Interventions

Cisplatin 263Radiotherapy 166Cetuximab 159Docetaxel 105Fluorouracil 104pembrolizumab 94Radiotherapy, Intensity-Modulated 83Carboplatin 80Paclitaxel 73Nivolumab 59Erlotinib Hydrochloride 35Surveys and Questionnaires 32Gemcitabine 32durvalumab 30Radiation 29Drug Therapy 25Immunohistochemistry 21Gefitinib 21Capecitabine 21tremelimumab 18Bevacizumab 18Surgical Procedures, Operative 17Sorafenib 17Magnetic Resonance Spectroscopy 17Ipilimumab 17Pemetrexed 16lenvatinib 15atezolizumab 15Radiosurgery 15Gene Expression Profiling 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Glutamine × Head & Neck × Clear all
NCT05054517 2021-09-23

Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity

National and Kapodistrian University of Athens

Completed
72 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT03015077 2017-01-10

Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase NA Completed
59 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡